I-SynerFuse, Inc., inkampani yangasese, yesiteji sezokwelapha egxile ekuthuthukisweni komqondo we-neuromodulation therapy we-neuromodulation wokwelapha ubuhlungu obungapheli bokubuyela emuva, namuhla umemezele ukuthi i-US Patent & Trademark Office (USPTO) ikhiphe i-US Patent Number. I-11,247,046 enesihloko esithi Izindlela Nezinhlelo Zokufaka i-Neuromodulation System endaweni yokwelashwa yomgogodla evulekile ngokuhlinzwa. Ukukhishwa kwelungelo lobunikazi le-'046 kuzokwengeza kwiphothifoliyo yenkampani ekhulayo yomhlaba wonke yelungelo lobunikazi okwamanje ehlanganisa amalungelo obunikazi angama-63 kanye nezicelo zelungelo lobunikazi ezishicilelwe.

Ilungelo lobunikazi elisanda kukhishwa le-'046 lihlanganisa ukubekwa okuqondile kwedivayisi ye-neuromodulation phezu kwe-dorsal root ganglion, inzwa eqondiwe eyaziwa ngokunikeza ukudambisa izinhlungu kumalungelo obunikazi lapho ilawulwa i-neuromodulation therapy. Le patent ihambisana ne-patent yase-US 10,675,458 ekhishwe ngaphambili, enesihloko esithi Izindlela Nezinhlelo Zokufaka I-Neuromodulation System kanye ne-Spinal Fixation System endaweni yokwelashwa evulekile yomgogodla, ehlanganisa inhlanganisela yokulungiswa komgogodla kanye ne-neuromodulation yokwelashwa ngesikhathi esisodwa kokulimala komgogodla kanye ubuhlungu obungapheli obuphansi emuva.

U-Justin Zenanko, umsunguli kanye nesikhulu esiphezulu se-SynerFuse uthe, “Le patent inezela kwiphothifoliyo yethu ekhulayo yamalungelo obunikazi emhlabeni wonke ukuze sisekele ukuthuthukiswa kwe-SynerFuse yenoveli yomqondo wokwelapha odidiyelwe wokwelapha ubuhlungu obungapheli futhi iphelelisa futhi ivikele ukutshalwa kwezimali kwethu okuqhubekayo imizamo yokwelapha kanye nokuthuthukiswa kwemikhiqizo.”

“Ezinye izinyathelo ohambweni lwethu zivele zigqame kancane,” kusho uMsunguli kanye noMphathi Omkhulu Wezesayensi uDkt. Greg Molnar. "Le patent ethile ivikela i-SynerFuse non-narcotic yokulawulwa kobuhlungu ukuze isetshenziswe esikhathini esizayo kubantu abaningi besiguli."

I-SynerFuse iPhini likaMongameli we-Intellectual Property uChris Frank, JD; Ummeli uJeffrey R. Stone wenkampani yabameli bebhizinisi i-Barnes & Thornburg LLP; kanye noMolnar bahole imizamo yempahla yengqondo yenkampani.

LOKHO ONGAKUTHATHE KULESI SIHLOKO:

10,675,458 patent, entitled Methods and Systems for Implanting a Neuromodulation System and a Spinal Fixation System at a Surgically Open Spinal Treatment Site, which covers the combination of spinal fixation and neuromodulation for the simultaneous treatment of a spinal injury and chronic lower back pain.
Justin Zenanko, co-founder and chief executive officer of SynerFuse said, “This patent adds to our growing worldwide patent portfolio to support the SynerFuse development of a novel integrated therapy concept for the treatment of chronic pain and further complements and protects our ongoing investment in clinical and product development efforts.
The newly issued ‘046 patent covers the direct placement of a neuromodulation device over the dorsal root ganglion, a nerve target known to provide pain relief to patents when subjected to neuromodulation therapy.